Tenax Therapeutics (TENX) Other Non-Current Liabilities (2012 - 2019)
Tenax Therapeutics recorded quarterly Other Non-Current Liabilities of $8775.0 in Q4 2019, down 31.08% quarter-over-quarter from $12732.0 in Q4 2018, and down 31.08% year-over-year from $12732.0 in Q4 2018.
Tenax Therapeutics' Other Non-Current Liabilities history runs 8 years deep, the most recent figure standing at $8775.0 for Q4 2019.
- In Q4 2019, Other Non-Current Liabilities fell 31.08% year-over-year to $8775.0; the TTM figure through Dec 2019 stood at $8775.0 (down 31.08% YoY), while the FY2019 annual figure was $8775.0, down 31.08% from the prior year.
- Other Non-Current Liabilities came in at $8775.0 for Q4 2019 at Tenax Therapeutics, down from $12732.0 in the prior quarter.
- In the past five years, Other Non-Current Liabilities ranged from a high of $579660.0 in Q1 2015 to a low of $8775.0 in Q4 2019.
- A 5-year average of $186881.6 and a median of $55750.0 in 2016 frame the typical range for Other Non-Current Liabilities.
- Across the five-year window, Other Non-Current Liabilities soared 1788.63% in 2015 and tumbled 89.29% in 2016, its largest moves.
- Tenax Therapeutics' Other Non-Current Liabilities stood at $524340.0 in 2015, then sank by 89.29% to $56180.0 in 2016, then slumped by 40.06% to $33673.0 in 2017, then sank by 62.19% to $12732.0 in 2018, then plunged by 31.08% to $8775.0 in 2019.
- According to Business Quant data, Other Non-Current Liabilities over the past three periods registered $8775.0, $12732.0, and $19376.0 for Q4 2019, Q4 2018, and Q3 2018 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Tenax Therapeutics | 542.72 Mn | 542.72 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 8,775.00 |
| Dec 31, 2018 | 12,732.00 |
| Sep 30, 2018 | 19,376.00 |
| Jun 30, 2018 | 24,551.00 |
| Mar 31, 2018 | 20,700.00 |
| Dec 31, 2017 | 33,673.00 |
| Sep 30, 2017 | 36,078.00 |
| Jun 30, 2017 | 72,157.00 |
| Mar 31, 2017 | 55,320.00 |
| Dec 31, 2016 | 56,180.00 |
| Sep 30, 2016 | 310,275.00 |
| Jun 30, 2016 | 370,405.00 |
| Mar 31, 2016 | 293,438.00 |
| Dec 31, 2015 | 524,340.00 |
| Apr 30, 2015 | 572,445.00 |
| Jan 31, 2015 | 579,660.00 |
| Oct 31, 2014 | 716,759.00 |
| Jul 31, 2014 | 680,680.00 |
| Apr 30, 2014 | -33,900.00 |
| Jan 31, 2014 | 1.08 Mn |
| Jan 31, 2013 | 65,592.00 |
| Oct 31, 2012 | 76,524.00 |